Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Desai J, Gan H, Barrow C, Jameson M, Atkinson V, Haydon A, Millward M, Begbie S, Brown M, Markman B, Patterson W, Hill A, Horvath L, Nagrial A, Richardson G, Jackson C, Friedlander M, Parente P, Tran B, Wang L, Chen Y, Tang Z, Huang W, Wu J, Zeng D, Luo L, Solomon B
(2020), J Clin Oncol, 38(19), 2140-50
DOI: 10.1200/JCO.19.02654
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Owen CN, Shoushtari AN, Chauhan D, Palmieri DJ, Lee B, Rohaan MW, Mangana J, Atkinson V, Zaman F, Young A, Hoeller C, Hersey P, Dummer R, Khattak MA, Millward M, Patel SP, Haydon A, Johnson DB, Lo S, Blank CU, Sandhu S, Carlino MS, Larkin JMG, Menzies AM, Long GV
(2020), Ann Oncol, 31(8), 1075-82
Treatment of High Risk Resected Melanoma in Australia: Current Landscape and Practises
Bhave P, Haydon A
(2020), Australas J Dermatol, 61(3), 203-9
DOI: 10.1111/ajd.13309
Caution in the age of optimism; a salient lesson in advanced melanoma
Roberts HN, Haydon A
(2020), Ann Transl Med, 8(11), 720
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Dummer R, Hauschild A, Santinami M, Atkinson V, Mandalà M, Kirkwood JM, Chiarion Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Gasal E, Tan M, Long GV, Schadendorf D
(2020), NEW ENGL J MED, 383(12), 1139-48
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial
Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C
(2020), J Clin Oncol, 38(33), 3925-36
DOI: 10.1200/JCO.20.02110
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
Atkinson V, Khattak A, Haydon A, Eastgate M, Roy A, Prithviraj P, Mueller C, Brignone C, Triebel F
(2020), J Immunother Cancer, 8(2), e001681
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia
Lickliter JD, Gan HK, Voskoboynik M, Arulananda S, Gao B, Nagrial A, Grimison P, Harrison M, Zou J, Zhang L, Luo S, Lahn M, Kallender H, Mannucci A, Somma C, Woods K, Behren A, Fernandez-Penas P, Millward M, Meniawy T
(2020), DRUG DES DEV THER, 14, 1177-89
DOI: 10.2147/DDDT.S243787
Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial
Ratnayake G, Reinwald S, Shackleton M, Moore M, Voskoboynik M, Ruben J, van Zelm MC, Yu D, Ward R, Smith R, Haydon A, Senthi S
(2020), INT J RADIAT ONCOL, 108(1), 150-6
First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
Geva R, Voskoboynik M, Dobrenkov K, Mayawala K, Gwo J, Wnek R, Chartash E, Long GV
(2020), CANCER-AM CANCER SOC, 126(22), 4926-35
DOI: 10.1002/cncr.33133
Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma
Yau WH, Ameratunga M
(2020), J Clin Pharm Ther, 45(5), 1172-4
DOI: 10.1111/jcpt.13112
Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials
Terbuch A, Tiu C, Candilejo IM, Scaranti M, Curcean A, Bar D, Estevez Timon M, Ameratunga M, Ang JE, Ratoff J, Minchom AR, Banerji U, de Bono JS, Tunariu N, Lopez JS
(2020), Clin Cancer Res, 26(18), 4805-13
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours
Ameratunga M, Braña I, Bono P, Postel-Vinay S, Plummer R, Aspegren J, Korjamo T, Snapir A, de Bono JS
(2020), Brit J Cancer, 123(12), 1730-6
The kinase polypharmacology landscape of clinical PARP inhibitors
Antolin AA, Ameratunga M, Banerji U, Clarke PA, Workman P, Al-Lazikani B
(2020), SCI REP-UK, 10(1), 2585
Metastatic melanoma presenting as intravenous tumour thrombus
Nguyen J, Clements W, McLean C, Haydon A, Moore M, Yap KS, Mar V, Shackleton M
(2020), J MED IMAG RADIAT ON, 64(6), 814-6
Case report: acute tumour lysis syndrome following encorafenib and binimetinib for v600E metastatic melanoma with large intra-abdominal mass
Byron Y, Nott L, Shackleton M
(2020), Melanoma Res, 30(6), 625-7
Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice
Dall GV, Vieusseux J, Seyed-Razavi Y, Godde N, Ludford-Menting M, Russell SM, Ashworth A, Anderson RL, Risbridger GP, Shackleton M, Britt KL
(2020), BREAST CANCER RES TR, 183(3), 565-75
Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, Ellen S, Phipps-Nelson J, Lai-Kwon J, Milne D, Russell L, Dax V, Diggens J, Kent H, Button-Sloan A, Elliott J, Shackleton M, Burridge H, Ftanou M
(2020), J Clin Med, 9(9), 2969
DOI: 10.3390/jcm9092969
Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial
Orchard, Suzanne G.; Lockery, Jessica E.; Gibbs, Peter; Polekhina, Galina; Wolfe, Rory; Zalcberg, John; Haydon, Andrew; McNeil, John J.; Nelson, Mark R.; Reid, Christopher M.; Kirpach, Brenda; Murray, Anne M.; Woods, Robyn L.; ,
(2020), CONTEMP CLIN TRIALS, 96), 106095
Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemic
Underhill, Craig; Parente, Phillip; McArthur, Grant; Haydon, Andrew; McLachlan, Sue Anne; Wong, Zee Wan; Segelov, Eva; ,
(2020), INTERN MED J, 50(10), 1282-1285.
DOI: 10.1111/imj.15012